
Last update at 2026-06-03T20:01:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
CorVel Full Year 2025 Earnings: EPS: US$1.85 (vs US$1.48 in FY 2024)
Sat 24 May 25, 12:03 PMCorVel Corp (CRVL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
Fri 23 May 25, 07:04 AMIf EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity
Mon 05 May 25, 06:15 PMSTAAR Surgical Announces Changes to Board of Directors
Thu 24 Apr 25, 09:00 PMWe Like CorVel's (NASDAQ:CRVL) Returns And Here's How They're Trending
Sun 06 Apr 25, 02:11 PMQ3 2025 CorVel Corp Earnings Call
Wed 05 Feb 25, 05:58 AMCorVel (NASDAQ:CRVL) shareholders have earned a 32% CAGR over the last five years
Wed 18 Dec 24, 02:14 PMCorVel Announces Retirement of V. Gordon Clemons
Fri 29 Nov 24, 06:30 PM| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 120.82M | 95.10M | 84.55M | 84.51M | 59.17M |
| Minority interest | - | - | - | - | - |
| Net income | 95.17M | 76.25M | 66.36M | 66.41M | 46.36M |
| Selling general administrative | 88.90M | 76.59M | 73.70M | 67.60M | 64.45M |
| Selling and marketing expenses | - | 26.25M | - | - | - |
| Gross profit | 209.73M | 171.69M | 158.26M | 152.11M | 123.62M |
| Reconciled depreciation | 29.54M | 26.25M | 25.12M | 23.92M | 23.44M |
| Ebit | 120.82M | 95.10M | 59.43M | 60.60M | 35.74M |
| Ebitda | 150.36M | 121.35M | 84.55M | 84.51M | 59.17M |
| Depreciation and amortization | 29.54M | 26.25M | 25.12M | 23.92M | 23.44M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 120.82M | 95.10M | 59.43M | 60.60M | 35.74M |
| Other operating expenses | 774.76M | 700.21M | 634.01M | 561.72M | 493.47M |
| Interest expense | - | - | -25.12100M | -23.91600M | 23.44M |
| Tax provision | 25.66M | 18.85M | 18.19M | 18.10M | 12.82M |
| Interest income | - | - | - | - | - |
| Net interest income | - | - | - | - | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 25.66M | 18.85M | 18.19M | 18.10M | 12.82M |
| Total revenue | 895.59M | 795.31M | 718.56M | 646.23M | 552.64M |
| Total operating expenses | 88.90M | 76.59M | 73.70M | 67.60M | 64.45M |
| Cost of revenue | 685.86M | 623.62M | 560.30M | 494.12M | 429.02M |
| Total other income expense net | - | - | 25.12M | 23.92M | 23.44M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 95.17M | 76.25M | 66.36M | 66.41M | 46.36M |
| Net income applicable to common shares | - | - | 66.36M | 66.41M | 46.36M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 545.98M | 474.42M | 393.92M | 415.25M | 424.76M |
| Intangible assets | 0.44M | 37.99M | 1.24M | 1.67M | 2.10M |
| Earning assets | - | - | - | - | - |
| Other current assets | 111.98M | 99.56M | 91407.00M | 84.90M | 64503.00M |
| Total liab | 223.99M | 226.77M | 191.75M | 202.85M | 204.36M |
| Total stockholder equity | 321.99M | 247.65M | 202.18M | 212.40M | 220.40M |
| Deferred long term liab | - | - | - | 1.69M | - |
| Other current liab | 46.84M | 129.26M | 35.68M | 48.01M | 57.11M |
| Common stock | 0.00500M | 0.00300M | 3.00M | 0.00300M | 3.00M |
| Capital stock | 0.00500M | 0.00300M | 0.00000M | 0.00300M | 0.00300M |
| Retained earnings | 903.09M | 807.92M | 731.67M | 665.30M | 598.89M |
| Other liab | - | - | - | 1.69M | - |
| Good will | 36.81M | 36.81M | 39.66M | 38.96M | 39.88M |
| Other assets | - | 0.00000M | - | 0.48M | 0.96M |
| Cash | 170.58M | 105.56M | 71.33M | 97.50M | 139.72M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 204.04M | 184.50M | 167.89M | 171.37M | 162.46M |
| Current deferred revenue | 132.28M | 29.96M | 107.00M | 95.58M | 79.01M |
| Net debt | -142.50500M | -74.16600M | -47.46900M | -54.36400M | -97.81800M |
| Short term debt | 8.13M | 8.86M | 9.90M | 13.35M | 12.77M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 28.08M | 31.40M | 23.86M | 43.14M | 41.90M |
| Other stockholder equity | -581.10300M | -560.27600M | -532.49200M | -452.91100M | -381.49100M |
| Property plant equipment | - | - | 82.77M | 76.27M | 88.04M |
| Total current assets | 386.69M | 302.23M | 243.77M | 264.99M | 268.94M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | 164.12M | 173.91M | 153.58M |
| Short term investments | - | - | - | - | - |
| Net receivables | 104.13M | 97.11M | 81.03M | 82.59M | 64.72M |
| Long term debt | - | - | - | - | - |
| Inventory | - | - | -91315.59300M | - | -64438.49700M |
| Accounts payable | 15.42M | 16.41M | 15.31M | 14.43M | 13.57M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 0.00300M | 0.00300M | 0.00300M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | 731.67M | 665.30M | 598.89M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 0.45M | 41144.15M | -0.22400M | 0.48M | 0.34M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 159.29M | 172.19M | 150.15M | 150.25M | 155.82M |
| Capital lease obligations | 28.08M | 31.40M | 23.86M | 43.14M | 41.90M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -35.75500M | -29.24000M | -26.32000M | -29.81900M | -17.24300M |
| Change to liabilities | - | - | -8.75600M | 9.47M | -3.35500M |
| Total cashflows from investing activities | -35.75500M | -29.24000M | -26.32000M | -29.81900M | -17.24300M |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -26.53900M | -35.76300M | -82.14300M | -79.61500M | -20.64300M |
| Change to operating activities | - | - | - | -14.28500M | 29.70M |
| Net income | 95.17M | 76.25M | 66.36M | 66.41M | 46.36M |
| Change in cash | 65.02M | 34.23M | -26.17500M | -42.21200M | 56.49M |
| Begin period cash flow | 105.56M | 71.33M | 97.50M | 139.72M | 83.22M |
| End period cash flow | 170.58M | 105.56M | 71.33M | 97.50M | 139.72M |
| Total cash from operating activities | 127.31M | 99.24M | 82.29M | 67.22M | 94.38M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 29.54M | 26.25M | 25.12M | 23.92M | 23.44M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -10.46300M | -17.90200M | 0.34M | -18.02200M | -0.97600M |
| Sale purchase of stock | -37.60500M | -45.71000M | -93.67500M | -90.08500M | -32.67100M |
| Other cashflows from financing activities | 11.07M | 9.95M | 11.53M | 10.47M | 12.03M |
| Change to netincome | - | - | 5.28M | 7.78M | -0.78700M |
| Capital expenditures | 35.76M | 29.24M | 26.32M | 29.82M | 17.24M |
| Change receivables | - | - | 0.34M | -18.02200M | -0.97600M |
| Cash flows other operating | - | - | -6.05500M | -22.33700M | -1.85600M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | -26.17500M | -42.21200M | 56.49M |
| Change in working capital | -1.82900M | -7.04600M | -14.47500M | -30.88400M | 25.37M |
| Stock based compensation | 5.71M | 4.98M | 5.56M | 5.20M | 4.98M |
| Other non cash items | 3.89M | 2.12M | 1.63M | 0.28M | 2.61M |
| Free cash flow | 91.56M | 70.00M | 55.97M | 37.40M | 77.14M |
Sector: Financial Services Industry: Insurance Brokers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRVL CorVel Corp |
-0.34 0.59% | 57.27 | 27.65 | 23.75 | 3.07 | 7.45 | 2.76 | 15.46 |
| AON Aon PLC |
-2.26 0.71% | 315.60 | 19.50 | 17.61 | 4.19 | 7.68 | 4.95 | 13.01 |
| AJG Arthur J Gallagher & Co |
-3.27 1.59% | 202.50 | 38.90 | 16.75 | 4.44 | 2.46 | 4.98 | 19.11 |
| WTW Willis Towers Watson PLC |
-5.43 2.12% | 250.98 | 25.57 | 16.03 | 2.81 | 2.80 | 3.28 | 15.43 |
| BRO Brown & Brown Inc |
-1.45 2.56% | 55.14 | 21.48 | 15.20 | 4.07 | 1.87 | 5.25 | 14.80 |
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
5128 Apache Plume Road, Fort Worth, TX, United States, 76109
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael G. Combs | Pres & CEO | 1964 |
| Mr. Brandon T. O'Brien | Chief Financial Officer | 1980 |
| Ms. Jennifer L. Yoss | VP of Accounting | 1978 |
| Mr. Maxim Shishin | Chief Information Officer | 1975 |
| Mr. Victor Gordon Clemons Sr. | Exec. Chairman | 1944 |
| Ms. Stefani P. Wendel | Investor Relation | NA |
| Sharon F. O'Connor | VP of Legal & HR | NA |
| Mr. Richard J. Schweppe | Sec. | 1955 |
| Mr. Victor Gordon Clemons Sr. | Executive Chairman | 1944 |
| Mr. Michael G. Combs | President & CEO | 1964 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.